Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s60	Lung cancer	Lung Adenocarcinoma	E616del	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL		2	NA	NA	MSKCC	17	40475061	40475063	CTT	-	17:g.40475061_40475063del	ENST00000264657.5:c.1847_1849del	0.09		38	401			1469	20/24								Durable Clinical Benefit			Non-Squamous			1358		LUAD		24.3121		1	Female			Matched	49.1																												0:Censor					73	PR	0	A*30:01	A*02:01	B*44:02	B*13:02	C*05:01	C*06:02	15.0	4350	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008324-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E616del	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: yes;3DHotspot: no	SIFT: NA;Polyphen-2: NA	In_Frame_Del	DEL	Diploid	2	SOMATIC	NA	MSKCC	17	40475061	40475063	CTT	-	17:g.40475061_40475063del	ENST00000264657.5:c.1847_1849del							15	20/24						76				0.2909						LUAD				1	Female	Never		Matched	14.6807954642			NO	ARAF	IMPACT410	NO	MSKCC	0	Brain	Adenocarcinoma	Lung	YES	Tumor	1033	YES	Metastasis		IV	NO	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003752-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E616G	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.398	Missense_Mutation	SNP	Diploid	2	SOMATIC	NA	MSKCC	17	40475063	40475063	T	C	17:g.40475063T>C	ENST00000264657.5:c.1847A>G							7	20/24						67		YES		0.1132						LUAD				2	Female	Never		Matched	6.8510378833			YES	EGFR	IMPACT410	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	152	NO	Primary	Note: The MCL1 copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	YES	NO	20	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003752-T03-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E616G	OncoKB: Likely Oncogenic, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.398	Missense_Mutation	SNP	Diploid	2	SOMATIC	NA	MSKCC	17	40475063	40475063	T	C	17:g.40475063T>C	ENST00000264657.5:c.1847A>G							7	20/24						67		YES		0.1801						LUAD				2	Female	Never		Matched	6.8510378833			YES	EGFR	IMPACT410	NO	MSKCC	1		Adenocarcinoma	Lung	YES	Tumor	586	NO	Primary		IV	YES	NO	30	AWD																													
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009586-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	K153N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 1;Polyphen-2: impact: benign, score: 0.321	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	40491341	40491341	C	A	17:g.40491341C>A	ENST00000264657.5:c.459G>T	0.26		345	969		427	12	5/24						55		YES		0.2838						LUAD		7.17		1	Female			Matched	11.7446363714					IMPACT410																							1:Progressed																	0.28	Commercial	2	11.32075472		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s51	Lung cancer	Lung Adenocarcinoma	R729H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.06;Polyphen-2: impact: benign, score: 0.181	Missense_Mutation	SNP			NA	NA	MSKCC	17	40468878	40468878	C	T	17:g.40468878C>T	ENST00000264657.5:c.2186G>A	0.17		42	210			1381	23/24								Durable Clinical Benefit			Non-Squamous			1175		LUAD		29.9302		1	Female			Matched	46.0666666667																												0:Censor					56	PR	1	A*02:01	A*11:01	B*45:01	B*18:01	C*07:01	C*06:02	0.0	3170	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s21	Lung cancer	Lung Adenocarcinoma	P725T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.987	Missense_Mutation	SNP			NA	NA	MSKCC	17	40468891	40468891	G	T	17:g.40468891G>T	ENST00000264657.5:c.2173C>A	0.08		12	147			293	23/24								Durable Clinical Benefit			Non-Squamous			274		LUAD		21.5852		1	Female			Matched	9.8																												0:Censor					74	CR	0	A*02:01	A*23:01	B*40:01	B*49:01	C*03:04	C*07:01	2.0	741	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s62	Lung cancer	Lung Adenocarcinoma	S273F	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.939	Missense_Mutation	SNP			NA	NA	MSKCC	17	40486047	40486047	G	A	17:g.40486047G>A	ENST00000264657.5:c.818C>T	0.05		15	265			1495	9/24								Durable Clinical Benefit			Non-Squamous			1336		LUAD		22.9979		1	Male			Matched	49.9																												1:Event					87	PR	0	A*02:01	A*01:01	B*57:01	B*51:01	C*05:01	C*06:02	20.0	2297	Never							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s75	Lung cancer	Lung Adenocarcinoma	F610L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: benign, score: 0.015	Missense_Mutation	SNP			NA	NA	MSKCC	17	40475080	40475080	G	T	17:g.40475080G>T	ENST00000264657.5:c.1830C>A	0.20		107	419			384	20/24								Durable Clinical Benefit			Non-Squamous			307		LUAD		14.883		1	Female			Matched	12.9666666667																												0:Censor					51	CR	1	A*02:01	A*03:01	B*44:02	B*50:01	C*05:01	C*04:01	0.0	594	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0008765-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V151D	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.328	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	40491348	40491348	A	T	17:g.40491348A>T	ENST00000264657.5:c.452T>A							6	5/24						59		NO		0.1699						LUAD				1	Male	Never		Matched	5.87231818569			NO	EGFR	IMPACT410	NO	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1040	YES	Metastasis		IV	YES	YES	20	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009586-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	K153N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 1;Polyphen-2: impact: benign, score: 0.321	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	40491341	40491341	C	A	17:g.40491341C>A	ENST00000264657.5:c.459G>T							12	5/24						51				0.2838						LUAD				1	Female	Former heavy		Matched	11.7446363714			NO	KRAS	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	1196	NO	Metastasis		IA	NO	YES		AWD																													
